PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30670973-6	2018	Mechanistically, midazolam suppressed tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) produced by LPS stimulated liver macrophages in vivo and bone marrow monocytes in vitro, and reduced the expression of major histocompatibility complex class II (MHC II), cluster of differentiation 40 and 86 (CD40 and CD86) on the cell surface.	Midazolam	17-26	interleukin 1 beta	Mus musculus	82-99	
30670973-6	2018	Mechanistically, midazolam suppressed tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) produced by LPS stimulated liver macrophages in vivo and bone marrow monocytes in vitro, and reduced the expression of major histocompatibility complex class II (MHC II), cluster of differentiation 40 and 86 (CD40 and CD86) on the cell surface.	Midazolam	17-26	interleukin 1 beta	Mus musculus	101-109	
29667111-3	2018	In this study, the effects of four intravenous anesthetics (propofol, thiamylal sodium, midazolam, and ketamine) on IL-1beta secretion, ROS, and bacterial survival in S. aureus-infected RAW264.7 cells were evaluated.	Midazolam	88-97	interleukin 1 beta	Mus musculus	116-124	
29667111-9	2018	However, thiamylal sodium and midazolam decreased IL-1beta mRNA and protein expression in a dose-dependent manner.	Midazolam	30-39	interleukin 1 beta	Mus musculus	50-58	
21400122-8	2012	Mice treated with midazolam had significantly lower serum IL-1beta (p=0.002), TNF-alpha (p=0.002), IL-6 (p=0.016), IL-10 (p=0.009), and TGF-beta (p=0.004) than saline-treated mice, with little impact on serum chemokine levels.	Midazolam	18-27	interleukin 1 beta	Mus musculus	58-66